Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Neurocognitive Disorders”

10,261 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 10,261 results

Not applicableUnknownNCT05019300
What this trial is testing

Long-term Neurocognitive and Psychiatric Consequences in Severe COVID-19 Survivors.

Who this might be right for
Covid19Neurocognitive Dysfunction
Pontificia Universidad Catolica de Chile 80
Early research (Phase 1)Study completedNCT01057030
What this trial is testing

Multiple Dose Japanese Bridging Study

Who this might be right for
Alzheimer Disease
Bristol-Myers Squibb 22
Not applicableNot Yet RecruitingNCT06624267
What this trial is testing

Test of Reproducibility of [15O]H20-PET Assessment of Brain Perfusion

Who this might be right for
Microvascular DiseaseMicrovascular ComplicationsDiabetes Mellitus Type 2+2 more
University Hospital Bispebjerg and Frederiksberg 8
Large-scale testing (Phase 3)Study completedNCT01194128
What this trial is testing

Facilitating Caregiver Adaptation to Patient Institutionalization

Who this might be right for
DementiaStrokeHeart Disease
University of Pittsburgh 217
Testing effectiveness (Phase 2)Study completedNCT00630500
What this trial is testing

Efficacy and Safety of Memantine for Parkinson's Disease Dementia (PDD) and Dementia With Lewy Bodies (DLB)

Who this might be right for
Dementia Associated With Parkinson's DiseaseDementia With Lewy Bodies
Helse Stavanger HF 75
Not applicableStudy completedNCT06845800
What this trial is testing

Peripheral Nerve Stimulation for Prognostic and Diagnostic Biomarker Identification in Disorders of Consciousness

Who this might be right for
Disorders of Consciousness Due to Severe Brain Injury
Fondazione Don Carlo Gnocchi Onlus 28
Testing effectiveness (Phase 2)Ended earlyNCT01561430
What this trial is testing

Study of LY2886721 in Mild Cognitive Impairment Due to Alzheimer's Disease or Mild Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
Eli Lilly and Company 70
Not applicableLooking for participantsNCT07036328
What this trial is testing

Transcranial Magnetic Stimulation to Slow Down Cognitive Decline in Alzheimer's Disease

Who this might be right for
Alzheimer DiseaseAlzheimer Disease, Early Onset
Willem de Haan 62
Not applicableLooking for participantsNCT05468905
What this trial is testing

China Longitudinal Aging and Cognitive Impairment Study

Who this might be right for
AgingMild Cognitive ImpairmentAlzheimer Disease+1 more
Second Affiliated Hospital, School of Medicine, Zhejiang University 4,000
Not applicableNot Yet RecruitingNCT07214194
What this trial is testing

Vagus Nerve Stimulation to Enhance Memory in Aging

Who this might be right for
Alzheimer DiseaseAging
Stanford University 150
Not applicableUnknownNCT04330222
What this trial is testing

Cambridge 7 Tesla Cerebral Small Vessel Disease Study

Who this might be right for
Cerebral Small Vessel DiseasesCerebral Small Vessel Ischemic DiseaseLacunar Stroke
University of Cambridge 210
Testing effectiveness (Phase 2)Study completedNCT01412151
What this trial is testing

Creatine Safety & Tolerability in Huntington's Disease

Who this might be right for
Huntington's Disease (HD)
Massachusetts General Hospital 10
Not applicableUnknownNCT04828902
What this trial is testing

Incidence of Postoperative Delirium After Cardiac Surgery in Adults.

Who this might be right for
Postoperative DeliriumAdult Cardiac SurgeryCovid19
Medical University of Gdansk 600
Large-scale testing (Phase 3)Study completedNCT03226522
What this trial is testing

Addressing Dementia Via Agitation-Centered Evaluation

Who this might be right for
Agitation in Patients With Dementia of the Alzheimer's TypeAlzheimer DiseaseAgitation,Psychomotor
Axsome Therapeutics, Inc. 366
Not applicableNot Yet RecruitingNCT06894953
What this trial is testing

AMPER Proof of Concept Study

Who this might be right for
Alzheimer's Dementia (AD)
University of Strathclyde 40
Early research (Phase 1)Study completedNCT03113812
What this trial is testing

Repeated Subcutaneous Administration of ABvac40 in Mild to Moderate Alzheimer's Disease Patients

Who this might be right for
Alzheimer's Disease
Araclon Biotech S.L. 24
Not applicableStudy completedNCT06701643
What this trial is testing

Can Neutrophil-to-Lymphocyte Ratio, Platelet Volume and Platelet Distribution Width Be Used as Indicators of Delirium?

Who this might be right for
Delirium - Postoperative
Ankara City Hospital Bilkent 221
Not applicableLooking for participantsNCT02855476
What this trial is testing

HDClarity: a Multi-site Cerebrospinal Fluid Collection Initiative to Facilitate Therapeutic Development for Huntington's Disease

Who this might be right for
Huntington's Disease
University College, London 2,500
Early research (Phase 1)Study completedNCT00745576
What this trial is testing

Study Evaluating The Potential Interaction Between Verapamil Immediate Release And SAM-531 When Co-Administered

Who this might be right for
Alzheimer Disease
Wyeth is now a wholly owned subsidiary of Pfizer 14
Early research (Phase 1)Study completedNCT02570997
What this trial is testing

Ascending Dose Study of CT1812 in Healthy Volunteers

Who this might be right for
Cognitive Impairment
Cognition Therapeutics 80
Load More Results